sitokiren   Click here for help

GtoPdb Ligand ID: 12196

Synonyms: compound 18 [PMID: 35939295] | SPH-3127 | SPH3127
Compound class: Synthetic organic
Comment: SPH3127 is an orally active direct renin inhibitor [1]. It induces a more potent antihypertensive effect in in vivo models than the approved renin inhibitor aliskiren. The chemical structure for SPH3127 matches that for the INN sitokiren (proposed INN list 130, Feb. 2024).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 110.61
Molecular weight 444.25
XLogP 1.75
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC(=O)NCCCn1nc(c2c1nc(C)cc2)[C@H](N(C(=O)[C@H]1CNCCO1)C1CC1)C
Isomeric SMILES COC(=O)NCCCn1nc([C@@H](C)N(C2CC2)C(=O)[C@H]2CNCCO2)c2ccc(C)nc12
InChI InChI=1S/C22H32N6O4/c1-14-5-8-17-19(26-27(20(17)25-14)11-4-9-24-22(30)31-3)15(2)28(16-6-7-16)21(29)18-13-23-10-12-32-18/h5,8,15-16,18,23H,4,6-7,9-13H2,1-3H3,(H,24,30)/t15-,18-/m1/s1
InChI Key GRTDDIZIUSADLD-CRAIPNDOSA-N
References
1. Iijima D, Sugama H, Takahashi Y, Hirai M, Togashi Y, Xie J, Shen J, Ke Y, Akatsuka H, Kawaguchi T et al.. (2022)
Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin Inhibitor.
J Med Chem, 65 (16): 10882-10897. [PMID:35939295]
2. Jing S, Xu R, Yang K, Liu W, Zhang L, Ke Y, Xia G, Lin Y. (2021)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPH3127: A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial.
Clin Ther, 43 (4): 735.e1-735.e14. [PMID:33653620]